Evidence map›Paper›PMID 34895139›Full record

ArticleBMC bioinformatics2021

Combining heterogeneous subgroups with graph-structured variable selection priors for Cox regression.

Katrin Madjar, Manuela Zucknick, Katja Ickstadt, Jörg Rahnenführer

Erratum issuedAbstract read
In one paragraph

Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Reduction techniques for survival analysis.Lifetime data analysis · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Katrin MadjarDepartment of Statistics, TU Dortmund University, 44221, Dortmund, Germany. madjar@statistik.tu-dortmund.de.ORCID http://orcid.org/0000-0001-6169-8105
Manuela ZucknickDepartment of Biostatistics, Oslo Centre for Biostatistics and Epidemiology, University of Oslo, 0317, Oslo, Norway.
Katja IckstadtDepartment of Statistics, TU Dortmund University, 44221, Dortmund, Germany.
Jörg RahnenführerDepartment of Statistics, TU Dortmund University, 44221, Dortmund, Germany.

Funding

Deutsche Forschungsgemeinschaft SFB 876, project A3Deutsche Forschungsgemeinschaft SFB 876, project C4Norwegian Research Council's center for research-based innovation "BigInsight" 237718
6 · The paper itself

Abstract

backgroundImportant objectives in cancer research are the prediction of a patient's risk based on molecular measurements such as gene expression data and the identification of new prognostic biomarkers (e.g. genes). In clinical practice, this is often challenging because patient cohorts are typically small and can be heterogeneous. In classical subgroup analysis, a separate prediction model is fitted using only the data of one specific cohort. However, this can lead to a loss of power when the sample size is small. Simple pooling of all cohorts, on the other hand, can lead to biased results, especially when the cohorts are heterogeneous.

resultsWe propose a new Bayesian approach suitable for continuous molecular measurements and survival outcome that identifies the important predictors and provides a separate risk prediction model for each cohort. It allows sharing information between cohorts to increase power by assuming a graph linking predictors within and across different cohorts. The graph helps to identify pathways of functionally related genes and genes that are simultaneously prognostic in different cohorts.

conclusionsResults demonstrate that our proposed approach is superior to the standard approaches in terms of prediction performance and increased power in variable selection when the sample size is small.

Indexed as

Bayes TheoremCohort StudiesGene ExpressionHumansSample SizeBayesian variable selectionCox proportional hazards modelGaussian graphical modelHeterogeneous cohortsMarkov random field priorSubgroup analysis

Identifiers

PMID34895139
PMCPMC8665528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.